Posted by Michael Wonder on 22 May 2026
More New Zealanders could benefit from funded vaccines from 2027
21 May 2026 - PHARMAC is proposing changes that would give more New Zealanders access to funded vaccines from 2027, including expanded access to the flu vaccine for young children.
The proposal includes changing the brands of funded meningococcal ACWY, pneumococcal, and influenza vaccines; and widening access to the influenza vaccine to all children from 6 months up to 5 years (6-59 months inclusive). The pneumococcal vaccine brand change also means there would be greater coverage for some people against the different types of pneumococcal bacteria.
